Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to version v2.16.5, while the previous version v2.16.4 has been removed. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.7%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.6%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check34 days agoChange DetectedThe page has undergone a significant update, with the removal of a citation regarding the mutational landscape of metastatic cancer and its replacement with a new version number, indicating a revision in the content.SummaryDifference0.3%
- Check41 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check48 days agoChange DetectedThe page has been updated to include a new version number and a reference to a bladder cancer article, while an erratum and the previous version number have been removed.SummaryDifference2%
Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.